Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
Geranylamine is an acyclic monoterpene amine that functions as a drug intermediate in the synthesis of various TRP channel modulators and antibacterial agents. Its structural properties make it a valuable precursor in medicinal chemistry, facilitating the development of compounds aimed at modulating ion channel activity and addressing bacterial resistance. This compound plays a crucial role in advancing research in pharmacology and therapeutic applications. -
Drug Intermediate
DFO-BCN is a chemical intermediate utilized in the synthesis of the PET/CT imaging agent DFO-CPC634 via click chemistry. This compound serves as a valuable tool in radiopharmaceutical development, enabling effective labeling and visualization in molecular imaging studies. Its role as a precursor enhances the efficiency of tracer synthesis, supporting research in diagnostic imaging applications. -
Drug Intermediate
((4-(tert-Butyl)phenyl)sulfonyl)methionine serves as a versatile drug intermediate in chemical synthesis. This compound is primarily utilized for the construction of peptides, facilitating the creation of diverse biological molecules. Its sulfonyl group enhances the stability and efficacy of peptide linkages, making it a valuable reagent in medicinal chemistry and drug development research. -
Drug Intermediate
2,4,6-Tribromo-3-methylphenol is a brominated phenolic compound widely utilized as a drug intermediate. It exhibits significant biological activity, serving as a precursor in the synthesis of various pharmaceuticals. Researchers employ this compound in studies related to organic synthesis and medicinal chemistry, facilitating the development of novel therapeutic agents. -
Drug Intermediate
(S)-Oxybutynin is a key pharmaceutical intermediate primarily involved in the synthesis of antifungal agents. This compound serves as an important building block in drug development, facilitating the creation of therapeutically relevant molecules. Its role in the synthesis pathway underscores its significance in both medicinal chemistry and pharmaceutical applications. -
Drug Intermediate
Boc-Pip-C-oxotetrahydropyrimidin-bromophenyl is a synthetic intermediate primarily employed in the development of molecular glues. This compound serves as a crucial building block for the synthesis of GSPT1 degrader-9, facilitating targeted protein degradation research and applications in drug discovery. Its structural properties make it valuable in the design of innovative therapeutic agents. -
Drug Intermediate
Ethyl 4'-hydroxy-[1,1'-biphenyl]-4-carboxylate is a key intermediate for drug synthesis, primarily targeting biphenyl-based derivatives. This compound serves as a versatile building block in the development of various pharmaceuticals, facilitating the preparation of more complex molecules in medicinal chemistry. Its structural features make it valuable for applications in drug discovery and development. -
Drug Intermediate
4-Methyl-5-nitropyridin-2-amine is a key drug intermediate utilized in the synthesis of pyrazolo-pyridine compounds with notable cytotoxic activity. This compound plays a significant role in pharmaceutical research and development, enabling the exploration of novel therapeutic agents. Its reactivity and structural properties make it a valuable tool for researchers focusing on targeted cancer therapies and related biological studies. -
Drug Intermediate
SCP-1 (Compound C-1) serves as a crucial intermediate in the synthesis of the non-opioid analgesic drug SRP-3D (DA). This compound is primarily utilized in research focused on neurological disorders, particularly pain-related conditions. Its role in drug development highlights its importance for advancing therapeutic strategies in pain management and related pathologies. -
Drug Intermediate
Cbz-Val-(triAc-β-D-glucoside methyl ester)-Cbz is a chemical intermediate primarily involved in the synthesis of antibody-drug conjugate (ADC) linkers. Its structural components facilitate the conjugation process, enhancing the efficacy of targeted drug delivery systems. This compound is essential in the development of sophisticated biopharmaceuticals aimed at improving therapeutic outcomes in cancer treatment. -
Drug Intermediate
2-Hydroxy-2-(2-methylpropyl)butanedioic acid serves as a key drug intermediate in the synthesis of diverse pharmaceutical compounds. Its unique structure facilitates the assembly of various active moieties, making it essential for drug development research. This reagent is valuable for chemists working on the design and synthesis of novel therapeutic agents. -
Drug Intermediate
5-Deoxy-D-ribose serves as a crucial building block in the synthesis of various anticancer compounds. This compound is employed as a drug intermediate, facilitating the development of therapeutic agents targeting cancer. Its structural properties enable researchers to explore diverse pathways in drug development and biochemical studies. -
Drug Intermediate
Thalidomide 5-Pip-C-oxotetrahydropyrimidin-bromophenyl is a synthetic intermediate utilized in the development of molecular glue therapies. This compound plays a significant role in the synthesis of GSPT1 degrader-9, supporting research in targeted protein degradation. Its versatile applications make it an important reagent for studies focused on novel therapeutic strategies in cellular regulation and disease modulation. -
Drug Intermediate
Crotonamide is a chemical intermediate utilized in the synthesis of epidermal growth factor receptor (EGFR) inhibitors. Its application in drug development facilitates the creation of therapeutic agents targeting various forms of cancer characterized by aberrant EGFR signaling. Crotonamide serves as a vital precursor in the production of innovative pharmaceuticals designed to address critical oncological challenges. -
Drug Intermediate
Doxorubicin-Boc (Dox-Boc) is a drug intermediate utilized in the synthesis of the Adamantane-Doxorubicin prodrug. This compound plays a crucial role in drug development by modifying the pharmacokinetic properties of doxorubicin, potentially enhancing its efficacy and reducing side effects. It serves as a valuable tool for researchers exploring innovative cancer treatment strategies. -
Drug Intermediate
Elcatonin, a synthetic analog of eel calcitonin, functions as a drug intermediate with significant implications in bone metabolism. It is known to increase bone mineral density and inhibit bone resorption, making it valuable in research related to osteoporosis and bone health. Additionally, Elcatonin exhibits central analgesic effects, thereby supporting applications in pain management studies. -
Drug Intermediate
(R,1R)-Tenofovir amibufenamide is a crucial drug intermediate utilized in the synthesis of tenofovir prodrugs. As a nucleoside reverse transcriptase inhibitor, tenofovir plays a significant role in the treatment of HIV and hepatitis B virus infections. This compound facilitates the purification process, thereby enhancing the development and application of antiviral therapeutics. -
Drug Intermediate
1-epi-Regadenoson hydrazone serves as a crucial intermediate in the synthesis of the α-isomer impurity of Regadenoson, a selective adenosine A2A receptor agonist. Its role in the development of this compound is significant for research in cardiovascular pharmacology and adenosine receptor modulation. This reagent is essential for investigations into therapeutic applications targeting the A2A receptor pathway. -
Drug Intermediate
Fmoc-Aeg-OMe is a methyl ester derivative of Fmoc-protected aminoethylglycine, serving as a versatile drug intermediate in the synthesis of polyamide nucleic acids. Its structural characteristics enable effective incorporation into polypeptide chains, facilitating advanced research in medicinal chemistry and nucleic acid therapeutics. This compound is valuable for applications that require precise modifications in peptide design and functionality. -
Drug Intermediate
2-Methoxyphenyl benzoate functions as a drug intermediate, playing a crucial role in organic synthesis. This compound exhibits potential biological activity as a building block in the development of pharmaceuticals. It is widely applicable in medicinal chemistry and is valuable for researchers involved in the synthesis of complex organic molecules. -
Drug Intermediate
Nile Red phenoxyacetic acid is a versatile pharmaceutical intermediate primarily utilized in the synthesis of GPR84 fluorescent probes. This compound’s unique properties enable its application in various research settings, facilitating the study of GPR84-related biological processes and pathways. It serves as a valuable tool for researchers investigating GPR84's role in inflammation and immune responses. -
Drug Intermediate
Fluticasone propionate-C-S-CH3 is a versatile drug intermediate utilized in the synthesis of antibody-drug conjugates (ADCs). This compound serves as a critical building block in the development of targeted therapies, facilitating the effective delivery of cytotoxic agents to cancer cells. Its structural modifications enhance stability and drug efficacy, making it an essential component in pharmaceutical research and development. -
Drug Intermediate
Coumestan is a secondary metabolite predominantly found in leguminous plants, serving as a valuable drug intermediate. It is utilized in the synthesis of various coumarin derivatives, including Coumestrol, Glytabastan B, and Coumestan Pks13 inhibitor. Coumestan exhibits a range of biological activities, making it relevant in research related to anti-cancer, anti-inflammatory, antioxidant, antibacterial, neuroprotective, and organ protective studies. -
Drug Intermediate Control
Fluprostenol lactone diol is a chemical intermediate utilized in the synthesis of Fluprostenol, a synthetic prostaglandin analogue. This reagent plays a crucial role in pharmaceutical research, particularly in investigating ocular and reproductive health, as Fluprostenol is known for its potent effects on intraocular pressure and reproductive functions. Its development contributes to advancements in drug formulation and therapeutic applications. -
Drug Intermediate Control
(S)-N-Boc-L-homoserine ethyl ester serves as a synthetic intermediate in the production of unsaturated caprolactams and monomer units for oxy-peptide nucleic acids. This compound is derived from L-homoserine and is utilized in various chemical research applications, particularly in the development of peptide-based therapeutics. Its role as an intermediate makes it essential for advancing studies in drug synthesis and nucleic acid chemistry. -
Drug Intermediate Control
Methyl (1S)-3-oxocyclopentaneacetate is a synthetic intermediate primarily used in pharmaceutical synthesis. This compound plays a crucial role in the development of bioactive molecules, facilitating the preparation of various drug candidates. Its unique structural features allow for diverse applications in the creation of new therapeutic agents within the pharmaceutical industry. -
Drug Intermediate
Montelukast impurity 15 is a chemical intermediate associated with the synthesis of Montelukast, a leukotriene receptor antagonist. This compound serves as a critical quality control standard for the assessment of purity during the production of Montelukast. It is utilized primarily in pharmaceutical research and development to ensure the integrity and efficacy of therapeutic formulations targeting respiratory conditions. -
Drug Intermediate
(R)-Benzyl mandelate is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a versatile building block in the development of various drug molecules, contributing to the advancement of medicinal chemistry. Its unique structural properties facilitate the production of diverse therapeutic agents, making it an essential reagent in chemical research applications. -
Drug Intermediate
6-Piperazin-1-yl-isoquinoline hydrochloride is a synthetic compound that serves as an important intermediate in pharmaceutical synthesis. It is utilized in the development of various bioactive molecules and pharmacological agents. Its structural properties facilitate further modification and exploration in drug discovery applications, particularly in the study of neuroactive compounds. -
Drug Intermediate
2-Chloroethyl (2-chloroethyl)phosphonate is an organophosphorus compound primarily utilized as a drug intermediate in organic synthesis. Its structure facilitates the formation of phosphonate derivatives, making it a valuable reagent in the development of various bioactive molecules. This compound is essential for researchers engaged in synthetic chemistry and pharmaceutical research aimed at discovering new therapeutic agents. -
Drug Intermediate
(R)-(4-Bromophenyl)(phenyl)methanamine is a synthetic intermediate widely utilized in organic synthesis. Its unique structure allows for the development of various pharmaceutical compounds, contributing to research in medicinal chemistry. This reagent plays a crucial role in the modification of molecular architectures, facilitating investigations into their biological activities and therapeutic potentials. -
Drug Intermediate
3-Amino benzamidoxime, also known as 3-amino-N'-hydroxybenzene-1-carboximidamide, is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its chemical structure facilitates the formation of various active pharmaceutical ingredients, making it a valuable reagent in drug development. Researchers leverage this compound for its role in optimizing synthetic pathways and enhancing the yield of biologically active molecules. -
Drug Intermediate
2-Methyl benzamideoxime is a synthetic intermediate primarily utilized in pharmaceutical synthesis. It serves as a versatile building block in the development of diverse drug compounds, facilitating modifications that enhance biological activity. Its application in the preparation of complex molecules makes it a valuable reagent in chemical research and drug development. -
Drug Intermediate
GS-1427 intermediate-2 is a crucial chemical intermediate involved in the synthesis of GS-1427, a potent therapeutic agent. This compound serves as an essential building block in the development of novel pharmaceuticals, facilitating research into targeted therapies. Its role in the synthetic pathway underscores its importance in drug discovery and optimization processes. -
Drug Intermediate
tBu-MTX-CO-NH-C2-O-C2-N3 is an azide compound that serves as a valuable drug intermediate for the synthesis of chemical inducers of dimerization. This compound facilitates the development of targeted therapeutics by enabling precise control over protein interactions. Its chemical structure allows for the incorporation of ligands such as Aurora A and Cereblon, making it suitable for a range of biological research applications, including studies focused on cell signaling and protein regulation. -
Drug Intermediate
Citraconimide is a 3-methylmaleimide derivative that exhibits thiol affinity, enabling it to undergo highly regioselective reactions with various alkyl thiols. Its derivatives demonstrate growth inhibitory activity against HeLa cancer cells, making it a valuable compound in cancer research. Additionally, Citraconimide can be modified through N-substitution, halogenation, and other chemical reactions, supporting its application in the design of bioactive molecules and the development of pharmaceutical agents. -
Drug Intermediate
3'-Fluoro-4'-methylacetanilide serves as a critical drug intermediate in the synthesis of various active pharmaceutical compounds. This compound exhibits properties that facilitate the development of biologically active molecules, making it valuable in medicinal chemistry and pharmaceutical research. Its utility in the preparation of targeted therapeutics underscores its importance in drug discovery and development processes. -
Drug Intermediate
2-Acetamidopyridine serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its structural properties facilitate the formation of various biologically active compounds, making it valuable in medicinal chemistry and drug development. This reagent is utilized in research applications that explore new therapeutic agents and optimize chemical pathways. -
Drug Intermediate
(S)-3-Amino-2,2-dimethyl-4-oxoazetidin-1-yl hydrogen sulfate serves as a versatile drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. Its unique structural features make it valuable in pharmaceutical research and development, particularly in designing new therapeutic agents. This compound is instrumental in exploring novel drug formulations and enhancing medicinal chemistry efforts. -
Drug Intermediate
(2R,4S)-Ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoate acts as a key drug intermediate in the synthesis of diverse bioactive compounds. This reagent is integral for researchers working in medicinal chemistry, facilitating the development of new therapeutic agents. Its structure supports various modifications, enabling the exploration of pharmacological properties and mechanisms of action in drug design. -
Drug Intermediate
(2S)-1-[(tert-Butoxy)carbonyl]-2-methylazetidine-2-carboxylic acid serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its chemical structure enables it to participate in various synthetic pathways, facilitating the development of innovative therapeutic agents. This reagent is essential for research applications focused on drug discovery and development. -
Drug Intermediate
4,4'-Trimethylenedipyridine is a versatile drug intermediate primarily utilized in the synthesis of diverse active pharmaceutical ingredients. Its chemical structure facilitates the development of compounds with potential therapeutic applications, contributing to advancements in medicinal chemistry. Researchers can employ this intermediate for the design and synthesis of novel drugs targeting various biological mechanisms. -
Drug Intermediate
7-Chloro-6-fluoro-1-(2-isopropyl-4-methyl-3-pyridyl)pyrido[2,3-d]pyrimidine-2,4-dione serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its unique structural features allow for the modification and development of derivatives with therapeutic potential. This compound is particularly valuable in medicinal chemistry research, facilitating investigations into novel drug candidates. -
Drug Intermediate
5-Chlororesorcinol dimethyl ether is a synthetic intermediate primarily used in pharmaceutical synthesis. It serves as a versatile building block for the development of various bioactive compounds. Research applications include the synthesis of potential therapeutic agents and other chemical derivatives in drug discovery processes. -
Drug Intermediate
Pentane-1,3,5-triol serves as a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. This triol structure allows for the modification and development of various compounds, facilitating research in drug development and medicinal chemistry. Its unique reactivity profile makes it essential for creating novel therapeutic agents across different biological applications. -
Drug Intermediate
Ethyl 3,3-dimethyl-4-nitrobutanoate is a key drug intermediate utilized in the synthesis of diverse bioactive compounds. This compound features a nitro group that can facilitate further chemical transformations, making it essential for the development of pharmaceutical agents. Its versatility in organic synthesis lends itself to various research applications, particularly in medicinal chemistry and drug discovery. -
Drug Intermediate
3-((tert-Butoxycarbonyl)amino)-7-fluoro-8-((triisopropylsilyl)ethynyl)naphthalen-1-yl trifluoromethanesulfonate functions primarily as a chemical intermediate in the synthesis of biologically active compounds. Its unique structure facilitates the introduction of diverse functional groups, making it valuable in medicinal chemistry and drug development. This compound is particularly relevant for research applications focused on the creation of novel therapeutic agents. -
Drug Intermediate
tert-Butyl (1H-pyrrol-1-yl)carbamate serves as a versatile drug intermediate in pharmaceutical synthesis. It facilitates the preparation of various active pharmaceutical ingredients, making it valuable in drug development and chemical research. This compound is particularly relevant for studies focused on pyrrole derivatives and their biological applications. -
Drug Intermediate
2-Chloro-1-(4-methoxy-1H-indol-3-yl)ethanone acts as a key intermediate in the synthesis of diverse bioactive compounds. This compound is essential for the development of pharmaceuticals, particularly in the creation of indole-based derivatives. Its structural properties facilitate various synthetic pathways, making it valuable for chemical research and development in medicinal chemistry. -
Drug Intermediate
5-Methoxy-7-azaindole serves as a versatile drug intermediate in the synthesis of a variety of bioactive compounds. Its structural framework allows for modifications that can enhance pharmacological properties. This reagent is primarily utilized in medicinal chemistry for the development of novel therapeutic agents.
